Chronic diseases are significant problems in South Africa. Chronic diseases' treatment outcomes are critical to the reduction of morbidity and mortality. There is limited data in South Africa on alcohol use and treatment outcomes of chronic diseases in older people. Understanding the association between alcohol use and chronic diseases treatment outcomes would inform potential interventions to address the duo. We analysed data from wave 1 of the Health and Ageing in Africa-a longitudinal Study in an INDEPTH community (HAALSI) study. We performed descriptive analysis to determine the prevalence of optimal chronic diseases' treatment outcomes (suppressed HIV viral load, normal blood pressure and normal blood sugar- euglycemia) and applied modified Poisson regression to determine the association between alcohol use and chronic diseases' treatment outcomes. The prevalence of optimal treatment outcomes was 87.4% suppressed viral load for those living with HIV, 42.7% normal blood pressure for hypertensives, 53.6% with euglycemia among diabetics and 52.4% with normal outcome parameters among those with multimorbidity. Alcohol use did not negatively impact the optimal treatment outcomes for HIV (aRR = 1.00, 95%CI 0.93-1.09), hypertension (aRR = 0.88, 95%CI 0.68-1.14), diabetes mellitus (aRR = 0.73, 95%CI 0.44-1.22), and multimorbidity (aRR = 1.00, 95%CI 0.93-1.09). Alcohol use was not significantly associated with treatment outcomes possibly due to underreporting of alcohol use. There is need to incorporate objective alcohol measurements and alcohol interventions in chronic diseases care settings. Furthermore, there is urgent need to strengthen the management of hypertension and diabetes, by adopting the strategies deployed for HIV management.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/s41598-025-91704-7 | DOI Listing |
JBI Evid Synth
March 2025
Health Quality Programs, Queen's University, Kingston, Ontario, Canada.
Objectives: The objective of this review is to identify, appraise, and synthesize available evidence on the experiences of informal caregivers providing HIV and/or AIDS care and the experiences of care received by people living with HIV and/or AIDS (PLHIV) in sub-Saharan Africa.
Introduction: PLHIV share the burden of the disease with their informal caregivers throughout their lives. Experiences of HIV- and/or AIDS-related caregiving and care receiving have a significant impact on the treatment and physiological health outcomes of both care receivers and caregivers.
Ann Ig
March 2025
Department of Global Public Health Policy and Governance, Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India.
Background: Seafarers experience unique challenges related to their profession, including risks for mental health. The present study explored the correlates of depression among seafarers in India.
Methods: Following ethics clearance, this cross-sectional study was conducted at an international shipping company in Mumbai, India.
Curr Opin Urol
March 2025
Department of Pediatric Urology, Oregon Health and Science University, Portland, Oregon, USA.
Purpose Of Review: There has been an explosion of creative uses of artificial intelligence (AI) in healthcare, with AI being touted as a solution for many problems facing the healthcare system. This review focuses on tools currently available to pediatric urologists, previews up-and-coming technologies, and highlights the latest studies investigating benefits and limitations of AI in practice.
Recent Findings: Imaging-driven AI software and clinical prediction tools are two of the more exciting applications of AI for pediatric urologists.
Prostate
March 2025
VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.
Background: Socioeconomic status and geographical location contribute to disparities in localized prostate cancer (PCa) treatment. We examined the impact of area of deprivation index (ADI) on initial treatment type for localized PCa in a North-American cohort.
Methods: We performed a retrospective analysis of patients diagnosed with localized PCa, treated within Henry Ford Health (HFH), between 1995 and 2022, with available ADI-data.
Thorac Cancer
March 2025
Department of Thoracic Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Background: Few malignancies provoke as many controversies about treatment as pleural mesothelioma. There is limited experience with novel radiotherapy techniques worldwide in adjuvant and particularly in neoadjuvant settings within multimodality treatment. The objective of the current study was to investigate the long-term outcome of neoadjuvant and adjuvant pleural intensity-modulated radiotherapy (IMRT) combined with macroscopic complete resection with or without chemotherapy.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!